Copyright (c) 2010 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=affyLatest Financial News for Affymax, Inc.en-usThu, 7 Jan 2010 12:44:15 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13h5l6g49/*http%3A//www.thestreet.com/_yahoo/story/10657272/1/amgens-anemia-drug-risks-vivus-aids-sleep-apnea-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/1640760530Thu, 7 Jan 2010 12:44:15 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12rcb0lng/*http%3A//www.thestreet.com/_yahoo/story/10657272/1/fda-to-review-amgen-drugs-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/2999551966Thu, 7 Jan 2010 12:44:15 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/100105/20100105005724.html?.v=1PALO ALTO, Calif.----Affymax, Inc. today announced that Arlene Morris, the company’s president and chief executive officer, will present at the 28th Annual JP Morgan Healthcare Conference on Wednesday, January 13, 2010 at 9:00 a.m.yahoo_finance/151844781Tue, 5 Jan 2010 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091210/affy8-k.htmlyahoo_finance/51159103Thu, 10 Dec 2009 20:24:57 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091201/20091201005310.html?.v=1PALO ALTO, Calif.----Affymax, Inc. today announced that management will present at the Piper Jaffray 21st Annual Healthcare Conference on Wednesday, December 2, 2009, at 2:00 p.m. ET .yahoo_finance/2468147480Tue, 1 Dec 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=13lofs9gc/*http%3A//www.thestreet.com/_yahoo/story/10634552/1/research-firm-lays-out-surprise-bio-events-for-2010-biobuzz.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/3984846851Mon, 30 Nov 2009 16:16:34 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091124/20091124005855.html?.v=1PALO ALTO, Calif.----Affymax, Inc. today announced the closing of its underwritten public offering of 4,726,027 shares of its common stock, which includes the full exercise of the underwriter’s overallotment option of 616,438 shares.yahoo_finance/1691263358Tue, 24 Nov 2009 21:05:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12aumb45o/*http%3A//sanjose.bizjournals.com/sanjose/stories/2009/11/16/daily69.html?ana=yfcpcyahoo_finance/3097255445Thu, 19 Nov 2009 15:05:21 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091119/us_affymax_stock_sale.html?.v=1Biotechnology company Affymax Inc. said late Wednesday it plans to sell 2.5 million new shares of stock in a public offering.yahoo_finance/744063642Thu, 19 Nov 2009 14:03:05 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091119/20091119005529.html?.v=1yahoo_finance/502565082Thu, 19 Nov 2009 14:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091118/20091118006278.html?.v=1yahoo_finance/4231842732Wed, 18 Nov 2009 21:01:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091110/20091110005726.html?.v=1yahoo_finance/2432005697Tue, 10 Nov 2009 13:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://finance.yahoo.com/q/is?s=affyyahoo_finance/1424269246Sat, 7 Nov 2009 14:04:14 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091105/affy8-k.htmlyahoo_finance/675498596Thu, 5 Nov 2009 21:09:27 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/a/r/a/affy.htmlyahoo_finance/50942198Thu, 5 Nov 2009 14:29:25 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091104/20091104006382.html?.v=1PALO ALTO, Calif., & DEERFIELD, Ill.----Affymax, Inc. and Takeda Pharmaceutical Global Research & Development Center, Inc., today announced data from a Phase 2 clinical trial of Hematide™ showing that Hematide increased hemoglobin and reduced or eliminated the need for blood transfusion in most patients with erythropoietin-induced pure red cell aplasia .yahoo_finance/3070110228Wed, 4 Nov 2009 22:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091104/us_earns_roundup_pulte_homes.html?.v=1Among the earnings stories for Wednesday, Nov. 4, from AP Financial News: Pulte Homes Inc. lost $361.4 million in the third quarter, but with the acquisition of Centex Corp., the homebuilder's new orders increased by more than a third.yahoo_finance/556757884Wed, 4 Nov 2009 19:17:58 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091104/us_earns_affymax.html?.v=2Biotechnology company Affymax Inc. said Wednesday its third-quarter loss narrowed on a boost in payments from its partner Takeda Pharmaceutical on the anemia drug candidate Hematide.yahoo_finance/2603716590Wed, 4 Nov 2009 15:18:03 Etc/GMThttp://us.rd.yahoo.com/finance/external/bizj/rss/SIG=12ak8f4d0/*http%3A//sanjose.bizjournals.com/sanjose/stories/2009/11/02/daily61.html?ana=yfcpcyahoo_finance/3642497163Wed, 4 Nov 2009 15:05:16 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091104/20091104005480.html?.v=1yahoo_finance/3205639284Wed, 4 Nov 2009 12:30:00 Etc/GMT